Table 4. Bleeding complications on brain imaging at day 3.

	RapidATT	StandardATT	p
Study cohort	N = 139	N = 33
Any Hemorrhagic Transformation, n (%)	16 (12)	1 (3)	0.20
Hemorrhagic infarction, n (%)	9 (6)	0 (0)	0.21
Parenchymal hematoma, n (%)	7 (5)	1 (3)	1.00
Symptomatic ICH after ATT onset, n (%)	3 (2)	0 (0)	1.00
Heparin cohort	N = 87	N = 8
Any Hemorrhagic Transformation, n (%)	10 (11)	0 (0)	0.59
Hemorrhagic infarction, n (%)	5 (6)	0 (0)	1.00
Parenchymal hematoma, n (%)	5 (6)	0 (0)	1.00
Symptomatic ICH after ATT onset, n (%)	2 (2)	0 (0)	1.00
Antiplatelets	N = 52	N = 25
Any Hemorrhagic Transformation, n (%)	6 (12)	1 (3)	0.42
Hemorrhagic infarction, n (%)	4 (8)	0 (0)	0.30
Parenchymal hematoma, n (%)	2 (4)	1 (4)	1.00
Symptomatic ICH after ATT onset, n (%)	1 (2)	0 (0)	1.00